• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国腹膜表面恶性肿瘤协会关于规范美国结直肠癌患者腹腔热灌注化疗(HIPEC)实施的共识指南。

Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.

作者信息

Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander H R, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat N J, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel J

机构信息

Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Ann Surg Oncol. 2014 May;21(5):1501-5. doi: 10.1245/s10434-013-3061-z. Epub 2013 Jun 21.

DOI:10.1245/s10434-013-3061-z
PMID:23793364
Abstract

BACKGROUND

The American Society of Peritoneal Surface Malignancies (ASPSM) is a consortium of cancer centers performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). This is a position paper from the ASPSM on the standardization of the delivery of HIPEC.

METHODS

A survey was conducted of all cancer centers performing HIPEC in the United States. We attempted to obtain consensus by the modified method of Delphi on seven key HIPEC parameters: (1) method, (2) inflow temperature, (3) perfusate volume, (4) drug, (5) dosage, (6) timing of drug delivery, and (7) total perfusion time. Statistical analysis was performed using nonparametric tests.

RESULTS

Response rates for ASPSM members (n = 45) and non-ASPSM members (n = 24) were 89 and 33 %, respectively. Of the responders from ASPSM members, 95 % agreed with implementing the proposal. Majority of the surgical oncologists favored the closed method of delivery with a standardized dual dose of mitomycin for a 90-min chemoperfusion for patients undergoing cytoreductive surgery for peritoneal carcinomatosis of colorectal origin.

CONCLUSIONS

This recommendation on a standardized delivery of HIPEC in patients with colorectal cancer represents an important first step in enhancing research in this field. Studies directed at maximizing the efficacy of each of the seven key elements will need to follow.

摘要

背景

美国腹膜表面恶性肿瘤协会(ASPSM)是一个由进行细胞减灭术联合腹腔内热灌注化疗(HIPEC)的癌症中心组成的联盟。这是ASPSM关于HIPEC实施标准化的立场文件。

方法

对美国所有开展HIPEC的癌症中心进行了一项调查。我们试图通过改良的德尔菲法就七个关键的HIPEC参数达成共识:(1)方法,(2)流入温度,(3)灌注液体积,(4)药物,(5)剂量,(6)给药时间,以及(7)总灌注时间。使用非参数检验进行统计分析。

结果

ASPSM成员(n = 45)和非ASPSM成员(n = 24)的回复率分别为89%和33%。在ASPSM成员的回复者中,95%同意实施该提议。大多数外科肿瘤学家倾向于采用封闭给药方法,对因结直肠癌腹膜转移而接受细胞减灭术的患者进行90分钟化疗灌注时使用标准化双剂量丝裂霉素。

结论

这项关于结直肠癌患者HIPEC标准化给药的建议是加强该领域研究的重要第一步。后续需要开展旨在使七个关键要素中的每一个要素的疗效最大化的研究。

相似文献

1
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.美国腹膜表面恶性肿瘤协会关于规范美国结直肠癌患者腹腔热灌注化疗(HIPEC)实施的共识指南。
Ann Surg Oncol. 2014 May;21(5):1501-5. doi: 10.1245/s10434-013-3061-z. Epub 2013 Jun 21.
2
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.美国腹膜表面恶性肿瘤协会对539例接受根治性细胞减灭术的结肠癌患者使用丝裂霉素C与奥沙利铂进行腹腔热灌注化疗的评估。
J Surg Oncol. 2014 Dec;110(7):779-85. doi: 10.1002/jso.23728. Epub 2014 Aug 2.
3
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.美国腹膜表面恶性肿瘤学会(ASPSM)对1013例伴有腹膜癌转移的结直肠癌患者的腹膜表面疾病严重程度评分(PSDSS)进行的多机构评估。
Ann Surg Oncol. 2014 Dec;21(13):4195-201. doi: 10.1245/s10434-014-3798-z. Epub 2014 May 23.
4
American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.美国腹膜表面恶性肿瘤学会关于明确结直肠癌患者细胞减灭术和腹腔内热灌注化疗预期效果的意见声明。
J Surg Oncol. 2014 Dec;110(7):777-8. doi: 10.1002/jso.23722. Epub 2014 Jul 8.
5
Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.结直肠癌腹膜转移患者行完全细胞减灭术和腹腔热灌注化疗后的复发模式。
J Surg Oncol. 2014 Jun;109(8):841-7. doi: 10.1002/jso.23597. Epub 2014 Mar 12.
6
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.采用完全细胞减灭术和奥沙利铂腹腔内热灌注化疗(HIPEC)治疗结直肠癌腹膜转移癌:一项比利时多中心前瞻性 II 期临床研究。
Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.
7
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.随机试验的8年随访:结直肠癌腹膜转移患者的细胞减灭术及腹腔热灌注化疗与全身化疗的对比
Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.
8
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.细胞减灭术联合腹腔热灌注化疗可改善部分腹部和盆腔恶性肿瘤所致腹膜癌患者的生存率:21例患者的研究结果
Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.
9
Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.结直肠癌腹膜转移癌的细胞减灭术及热灌注化疗结果
J Surg Oncol. 2009 Sep 15;100(4):306-10. doi: 10.1002/jso.21332.
10
Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an Asian perspective.细胞减灭术和腹腔内热灌注化疗后的生活质量:亚洲视角。
Ann Surg Oncol. 2013 Dec;20(13):4219-23. doi: 10.1245/s10434-013-3133-0. Epub 2013 Sep 6.

引用本文的文献

1
Appendiceal mucinous neoplasms: Optimizing treatment strategies based on clinical, histological, and molecular features.阑尾黏液性肿瘤:基于临床、组织学和分子特征优化治疗策略。
World J Clin Oncol. 2025 Aug 24;16(8):109088. doi: 10.5306/wjco.v16.i8.109088.
2
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis.基于质量的反应性药物筛选以指导阑尾和结直肠癌伴腹膜转移的个体化热灌注化疗的可行性研究
Ann Surg Oncol. 2025 May 30. doi: 10.1245/s10434-025-17517-0.
3
Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis.
腹膜癌指数与结直肠癌腹膜转移的影像学评估相关。
Ann Surg Oncol. 2025 Apr;32(4):2923-2931. doi: 10.1245/s10434-024-16737-0. Epub 2024 Dec 27.
4
Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy.顺铂在全身化疗与胸腔或腹腔热化疗中的药代动力学。
Cancer Chemother Pharmacol. 2024 Dec 26;95(1):13. doi: 10.1007/s00280-024-04727-8.
5
An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.一种用于评估热灌注腹腔化疗对结直肠癌治疗效果的类器官模型
Ann Surg Oncol. 2025 Mar;32(3):1925-1940. doi: 10.1245/s10434-024-16469-1. Epub 2024 Nov 26.
6
Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery.血栓弹力图变化与肿瘤细胞减灭术后的并发症相关。
Pleura Peritoneum. 2024 Oct 18;9(3):113-119. doi: 10.1515/pp-2023-0018. eCollection 2024 Sep.
7
Intra-abdominal temperature variation during hyperthermic intraperitoneal chemotherapy evaluated via computational fluid dynamics modeling.通过计算流体动力学建模评估热腹腔内化疗期间的腹腔内温度变化。
J Gastrointest Oncol. 2024 Aug 31;15(4):1847-1860. doi: 10.21037/jgo-24-352. Epub 2024 Aug 28.
8
Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis.细胞减灭术联合腹腔热灌注化疗治疗胰腺癌腹膜转移患者的疗效和安全性。
World J Surg Oncol. 2024 Sep 2;22(1):212. doi: 10.1186/s12957-024-03464-9.
9
Has the open surgical approach in colorectal cancer really become uncommon?结直肠癌的开放手术方式真的变得不常见了吗?
World J Gastrointest Surg. 2024 Jun 27;16(6):1485-1492. doi: 10.4240/wjgs.v16.i6.1485.
10
Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.肝细胞癌患者细胞减灭术和腹腔热灌注化疗治疗腹膜转移的长期生存结果。
World J Surg Oncol. 2024 May 31;22(1):144. doi: 10.1186/s12957-024-03426-1.